-
1.PYRIDO [2, 3-D] PYRIMIDIN-7-ONE COMPOUNDS AS INHIBITORS OF P13K-ALPHA FOR THE TREATMENT OF CANCER 审中-公开
标题翻译: PYRIDO [2,3-D] PYRIMIDIN-7-ONE化合物作为P13K-ALPHA的抑制剂治疗癌症公开(公告)号:US20100150827A1
公开(公告)日:2010-06-17
申请号:US12595226
申请日:2008-04-11
申请人: Chris A. Buhr , William Bajjalieh , Anagha Abhijit Joshi , Katherine Lara , Sunghoon Ma , Charles K. Marlowe , Longcheng Wang , Bryan K.S. Yeung
发明人: Chris A. Buhr , William Bajjalieh , Anagha Abhijit Joshi , Katherine Lara , Sunghoon Ma , Charles K. Marlowe , Longcheng Wang , Bryan K.S. Yeung
IPC分类号: A61K31/519 , C07D471/04 , A61K51/00 , A61K39/395 , A61P35/00 , A61P35/02
CPC分类号: C07D471/04 , A61K31/519
摘要: The invention is directed to a Compound of Formula I, II, or III. The invention provides compounds that inhibit, regulate, and/or modulate PI3K that are useful in the treatment of hyperproliferatives diseases, such as cancer.
摘要翻译: 本发明涉及式I,II或III的化合物。 本发明提供抑制,调节和/或调节PI3K的化合物,其可用于治疗过度增殖性疾病如癌症。
-
公开(公告)号:US20090062274A1
公开(公告)日:2009-03-05
申请号:US11988859
申请日:2006-10-09
申请人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Longcheng Wang , Bryan K.S. Yeung
发明人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Longcheng Wang , Bryan K.S. Yeung
IPC分类号: A61K31/5377 , C07D471/04 , A61K31/519
CPC分类号: C07D471/04
摘要: The invention is directed to Compounds of Formula I and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
摘要翻译: 本发明涉及式I化合物及其药学上可接受的盐或溶剂合物,以及制备和使用该化合物的方法。
-
公开(公告)号:US20090270430A1
公开(公告)日:2009-10-29
申请号:US11988848
申请日:2006-10-09
申请人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Morrison Mac , John M. Nuss , Longcheng Wang , Yong Wang , Bryan K.S. Yeung
发明人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Morrison Mac , John M. Nuss , Longcheng Wang , Yong Wang , Bryan K.S. Yeung
IPC分类号: A61K31/519 , C07D471/04 , A61P35/00
CPC分类号: C07D471/04 , A61K9/0095 , A61K9/02 , A61K9/08 , A61K9/10 , A61K9/2018 , A61K9/4858
摘要: The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
摘要翻译: 本发明涉及式I化合物及其药学上可接受的盐或溶剂合物,以及制备和使用该化合物的方法。
-
公开(公告)号:US20110237608A1
公开(公告)日:2011-09-29
申请号:US13152045
申请日:2011-06-02
申请人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Morrison Mac , John M. Nuss , Longcheng Wang , Yong Wang , Bryan K.S. Yeung
发明人: Tae-Gon Baik , Chris A. Buhr , Katherine Lara , Sunghoon Ma , Morrison Mac , John M. Nuss , Longcheng Wang , Yong Wang , Bryan K.S. Yeung
IPC分类号: A61K31/519 , C07D471/04 , A61P35/00 , A61P35/02
CPC分类号: C07D471/04 , A61K9/0095 , A61K9/02 , A61K9/08 , A61K9/10 , A61K9/2018 , A61K9/4858
摘要: The invention is directed to Compounds of Formula I: and pharmaceutically acceptable salts or solvates thereof, as well as methods of making and using the compounds.
摘要翻译: 本发明涉及式I化合物及其药学上可接受的盐或溶剂合物,以及制备和使用该化合物的方法。
-
-
-